Moreover, preclinical studies on SYK expression (upregulated in IPF case 2) have reported that its inhibition suppresses TGF-β1-induced myofibroblast activation and progression of fibrosis in the liver, kidney, skin, and lung [37–39]. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.